drugset / Trial / NCT01476488

Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients

NCT01476488

NaSingle-groupOpen-labelTreatment

Summary

This study was designed to compare the pharmacokinetics of Prograf and Advagraf in stable pediatric kidney transplant recipients. Enrolled patients on prograf will have pharmacokinetic study of tacrolimus for 24 hours and after that, the same dose of advagraf will be prescribed. The patients will have another pharmacokinetic study of tacrolimus after conversion to advagraf.

Timeline

Start
2011-07
Primary completion
2013-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule

Indications

No indication recorded.